US5422354A
(en)
*
|
1990-07-23 |
1995-06-06 |
Pfizer Inc |
Quinuclidine derivatives
|
US5716965A
(en)
*
|
1991-05-22 |
1998-02-10 |
Pfizer Inc. |
Substituted 3-aminoquinuclidines
|
ATE142199T1
(de)
*
|
1991-06-20 |
1996-09-15 |
Pfizer |
Fluoralkoxybenzylaminoderivate stickstoffhaltiger heterocyclen
|
TW202432B
(xx)
*
|
1991-06-21 |
1993-03-21 |
Pfizer |
|
HU9400728D0
(en)
*
|
1991-09-26 |
1994-06-28 |
Pfizer |
Fused tricyclic nitrogen containing heterocycles as substance p receptor antagonists
|
EP0613458B1
(en)
*
|
1991-11-12 |
1998-01-07 |
Pfizer Inc. |
Acyclic ethylenediamine derivatives as substance p receptor antagonists
|
ATE209186T1
(de)
*
|
1992-05-18 |
2001-12-15 |
Pfizer |
Überbrückte azabicyclische derivate als substanz p antagonisten
|
AU4396193A
(en)
*
|
1992-08-04 |
1994-03-03 |
Pfizer Inc. |
3-benzylamino-2-phenyl-piperidine derivatives as substance p receptor antagonists
|
EP1114823A3
(en)
*
|
1992-08-19 |
2001-07-18 |
Pfizer Inc. |
Substituted benzylamino nitrogen containing non-aromatic heterocycles
|
EP0675886B1
(en)
*
|
1992-12-10 |
2000-07-05 |
Pfizer Inc. |
Aminomethylene substituted non-aromatic heterocycles and use as substance p antagonists
|
US5830854A
(en)
*
|
1992-12-14 |
1998-11-03 |
Merck Sharp & Dohme, Limited |
Method of treating cystic fibrosis using a tachykinin receptor antagonist
|
US5340826A
(en)
*
|
1993-02-04 |
1994-08-23 |
Pfizer Inc. |
Pharmaceutical agents for treatment of urinary incontinence
|
US5393762A
(en)
*
|
1993-06-04 |
1995-02-28 |
Pfizer Inc. |
Pharmaceutical agents for treatment of emesis
|
EP0655246A1
(en)
*
|
1993-11-30 |
1995-05-31 |
Pfizer Inc. |
Substance P antagonists for the treatment of disorders caused by helicobacter pylori or other spiral urease-positive gram-negative bacteria
|
FR2725900B1
(fr)
*
|
1994-10-21 |
1997-07-18 |
Sanofi Sa |
Utilisation d'antagonistes des recepteurs nk1 pour la preparation de medicaments a action cardioregulatrice
|
IL116249A
(en)
*
|
1994-12-12 |
2003-07-06 |
Pfizer |
Nk-1 receptor antagonists for the treatment of neuronal damage and stroke
|
GB9502582D0
(en)
*
|
1995-02-10 |
1995-03-29 |
Smithkline Beecham Plc |
Novel process
|
GB9510459D0
(en)
*
|
1995-05-24 |
1995-07-19 |
Zeneca Ltd |
Bicyclic amines
|
WO1997043286A1
(en)
*
|
1996-05-13 |
1997-11-20 |
Zeneca Limited |
Bicyclic amines as insecticides
|
WO1998006720A1
(fr)
*
|
1996-08-09 |
1998-02-19 |
Eisai Co., Ltd. |
Derives de benzopiperidine
|
GB9623944D0
(en)
*
|
1996-11-15 |
1997-01-08 |
Zeneca Ltd |
Bicyclic amine derivatives
|
GB9624114D0
(en)
*
|
1996-11-20 |
1997-01-08 |
Zeneca Ltd |
Pesticidal bicyclic amine derivatives
|
SK69299A3
(en)
|
1996-11-26 |
2000-01-18 |
Zeneca Ltd |
8-azabicyclo[3.2.1]octane-, 8-azabicyclo[3.2.1]oct-6-ene-, 9-azabicyclo[3.3.1]nonane-, 9-aza-3-oxabicyclo[3.3.1]nonane- and 9-aza-3-thiabicyclo[3.3.1]nonane derivatives, their preparation and their use as insecticides
|
GB9624611D0
(en)
*
|
1996-11-26 |
1997-01-15 |
Zeneca Ltd |
Bicyclic amine compounds
|
WO2001023385A2
(en)
*
|
1999-09-27 |
2001-04-05 |
Georgetown University |
Novel tropane analogs
|
JP2001172178A
(ja)
*
|
1999-10-25 |
2001-06-26 |
Pfizer Prod Inc |
偏頭痛治療用のnk−1レセプターアンタゴニスト及びエレトリプタン
|
US7163949B1
(en)
|
1999-11-03 |
2007-01-16 |
Amr Technology, Inc. |
4-phenyl substituted tetrahydroisoquinolines and use thereof
|
PT1246806E
(pt)
|
1999-11-03 |
2008-04-03 |
Amr Technology Inc |
Tetra-hidroisoquinolinas aril- e heteroaril-substituídas e sua utilização no bloqueio da recaptação de norepinefrina, dopamina e serotonina.
|
JP5132864B2
(ja)
|
2000-07-11 |
2013-01-30 |
アルバニー モレキュラー リサーチ, インコーポレイテッド |
4−フェニル置換テトラヒドロイソキノリンおよびその使用方法
|
US20020049211A1
(en)
*
|
2000-09-06 |
2002-04-25 |
Sobolov-Jaynes Susan Beth |
Combination treatment for depression and anxiety
|
EP1192952A3
(en)
*
|
2000-09-28 |
2003-03-26 |
Pfizer Products Inc. |
Combination, for treating depression and anxiety, containing an NK-3 receptor antagonist and a CNS penetrant NK-1 receptor antagonist
|
BRPI0513359A
(pt)
|
2004-07-15 |
2008-05-06 |
Amr Technology Inc |
tetraidroisoquinolinas substituìdas por arila e heteroarila e uso destes para bloquear a recaptação de norepinefrina, dopamina, e serotonina
|
ES2382814T3
(es)
|
2005-05-17 |
2012-06-13 |
Merck Sharp & Dohme Ltd. |
Ácido cis-4-[(4-clorofenil)sulfonil]-4-(2,5-difluorofenil)ciclohexanopropanoico para el tratamiento del cáncer
|
CA2615403C
(en)
|
2005-07-15 |
2015-06-16 |
Amr Technology, Inc. |
Aryl-and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
|
AU2006297443B2
(en)
|
2005-09-29 |
2010-08-12 |
Merck Sharp & Dohme Corp. |
Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
|
GB0603041D0
(en)
|
2006-02-15 |
2006-03-29 |
Angeletti P Ist Richerche Bio |
Therapeutic compounds
|
US8173629B2
(en)
|
2006-09-22 |
2012-05-08 |
Merck Sharp & Dohme Corp. |
Method of treatment using fatty acid synthesis inhibitors
|
US20110218176A1
(en)
|
2006-11-01 |
2011-09-08 |
Barbara Brooke Jennings-Spring |
Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development
|
EA016079B1
(ru)
|
2007-01-10 |
2012-01-30 |
Институто Ди Ричерке Ди Биолоджиа Молеколаре П. Анджелетти Спа |
Амидзамещенные индазолы в качестве ингибиторов поли(adp-рибоза)полимеразы (parp)
|
KR20090112722A
(ko)
|
2007-01-24 |
2009-10-28 |
글락소 그룹 리미티드 |
3,5-디아미노-6-(2,3-디클로로페닐)-1,2,4-트리아진 또는 r(-)-2,4-디아미노-5-(2,3-디클로로페닐)-6-플루오로메틸 피리미딘 및 nk1을 포함하는 제약 조성물
|
WO2008120653A1
(ja)
|
2007-04-02 |
2008-10-09 |
Banyu Pharmaceutical Co., Ltd. |
インドールジオン誘導体
|
WO2009002495A1
(en)
|
2007-06-27 |
2008-12-31 |
Merck & Co., Inc. |
4-carboxybenzylamino derivatives as histone deacetylase inhibitors
|
KR20100126467A
(ko)
|
2008-03-03 |
2010-12-01 |
타이거 파마테크 |
티로신 키나아제 억제제
|
US9156812B2
(en)
|
2008-06-04 |
2015-10-13 |
Bristol-Myers Squibb Company |
Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine
|
AR071997A1
(es)
|
2008-06-04 |
2010-07-28 |
Bristol Myers Squibb Co |
Forma cristalina de 6-((4s)-2-metil-4-(2-naftil)-1,2,3,4-tetrahidroisoquinolin-7-il)piridazin-3-amina
|
UA105182C2
(ru)
|
2008-07-03 |
2014-04-25 |
Ньюрексон, Інк. |
Бензоксазины, бензотиазины и родственные соединения, которые имеют ингибирующую nos активность
|
EP2413932A4
(en)
|
2009-04-01 |
2012-09-19 |
Merck Sharp & Dohme |
INHIBITORS OF AKT ACTIVITY
|
CA2760837C
(en)
|
2009-05-12 |
2018-04-03 |
Albany Molecular Research, Inc. |
7-([1,2,4]triazolo[1,5-.alpha.]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoquinoline and use thereof
|
US8815894B2
(en)
|
2009-05-12 |
2014-08-26 |
Bristol-Myers Squibb Company |
Crystalline forms of (S)-7-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoquinoline and use thereof
|
ES2446971T3
(es)
|
2009-05-12 |
2014-03-11 |
Albany Molecular Research, Inc. |
Tetrahidroisoquinolinas sustituidas con arilo, heteroarilo, y heterociclo y su uso
|
KR101485645B1
(ko)
|
2009-10-14 |
2015-01-22 |
머크 샤프 앤드 돔 코포레이션 |
p53 활성을 증가시키는 치환된 피페리딘 및 그의 용도
|
EP2584903B1
(en)
|
2010-06-24 |
2018-10-24 |
Merck Sharp & Dohme Corp. |
Novel heterocyclic compounds as erk inhibitors
|
EP2601293B1
(en)
|
2010-08-02 |
2017-12-06 |
Sirna Therapeutics, Inc. |
RNA INTERFERENCE MEDIATED INHIBITION OF CATENIN (CADHERIN-ASSOCIATED PROTEIN), BETA 1 (CTNNB1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
LT2606134T
(lt)
|
2010-08-17 |
2019-07-25 |
Sirna Therapeutics, Inc. |
Hepatito b viruso (hbv) geno raiškos slopinimas, tarpininkaujant rnr interferencijai naudojant mažą interferuojančią nukleorūgštį (sina)
|
US8883801B2
(en)
|
2010-08-23 |
2014-11-11 |
Merck Sharp & Dohme Corp. |
Substituted pyrazolo[1,5-a]pyrimidines as mTOR inhibitors
|
US8946216B2
(en)
|
2010-09-01 |
2015-02-03 |
Merck Sharp & Dohme Corp. |
Indazole derivatives useful as ERK inhibitors
|
EP2615916B1
(en)
|
2010-09-16 |
2017-01-04 |
Merck Sharp & Dohme Corp. |
Fused pyrazole derivatives as novel erk inhibitors
|
EP2632472B1
(en)
|
2010-10-29 |
2017-12-13 |
Sirna Therapeutics, Inc. |
Rna interference mediated inhibition of gene expression using short interfering nucleic acids (sina)
|
EP2654748B1
(en)
|
2010-12-21 |
2016-07-27 |
Merck Sharp & Dohme Corp. |
Indazole derivatives useful as erk inhibitors
|
WO2012143874A1
(en)
|
2011-04-21 |
2012-10-26 |
Piramal Healthcare Limited |
A process for the preparation of morpholino sulfonyl indole derivatives
|
US9023865B2
(en)
|
2011-10-27 |
2015-05-05 |
Merck Sharp & Dohme Corp. |
Compounds that are ERK inhibitors
|
EP2791135B8
(en)
*
|
2011-12-12 |
2018-07-18 |
KemPharm Consulting Inc. |
Anabasine derivatives targeting the nicotinic acetylcholine receptors
|
EP3453762B1
(en)
|
2012-05-02 |
2021-04-21 |
Sirna Therapeutics, Inc. |
Short interfering nucleic acid (sina) compositions
|
AU2013323508B2
(en)
|
2012-09-28 |
2017-11-02 |
Merck Sharp & Dohme Corp. |
Novel compounds that are ERK inhibitors
|
EP2919788A4
(en)
|
2012-11-14 |
2016-05-25 |
Univ Johns Hopkins |
METHOD AND COMPOSITIONS FOR TREATING SCHIZOPHRENIA
|
AU2013352568B2
(en)
|
2012-11-28 |
2019-09-19 |
Merck Sharp & Dohme Llc |
Compositions and methods for treating cancer
|
TW201429969A
(zh)
|
2012-12-20 |
2014-08-01 |
Merck Sharp & Dohme |
作爲hdm2抑制劑之經取代咪唑吡啶
|
US9540377B2
(en)
|
2013-01-30 |
2017-01-10 |
Merck Sharp & Dohme Corp. |
2,6,7,8 substituted purines as HDM2 inhibitors
|
EP3041938A1
(en)
|
2013-09-03 |
2016-07-13 |
Moderna Therapeutics, Inc. |
Circular polynucleotides
|
JP6639651B2
(ja)
*
|
2015-09-04 |
2020-02-05 |
ヤンセン ファーマシューティカ エヌ.ベー. |
疼痛のための治療化合物及びその合成
|
EP3525785A4
(en)
|
2016-10-12 |
2020-03-25 |
Merck Sharp & Dohme Corp. |
KDM5 INHIBITORS
|
EP3706747A4
(en)
|
2017-11-08 |
2021-08-04 |
Merck Sharp & Dohme Corp. |
PRMT5 INHIBITORS
|
WO2019094311A1
(en)
|
2017-11-08 |
2019-05-16 |
Merck Sharp & Dohme Corp. |
Prmt5 inhibitors
|
US11981701B2
(en)
|
2018-08-07 |
2024-05-14 |
Merck Sharp & Dohme Llc |
PRMT5 inhibitors
|
US11993602B2
(en)
|
2018-08-07 |
2024-05-28 |
Merck Sharp & Dohme Llc |
PRMT5 inhibitors
|
AU2019317549A1
(en)
|
2018-08-07 |
2021-02-25 |
Msd International Gmbh |
PRMT5 inhibitors
|